Company Information

CIN
Status
Date of Incorporation
05 February 2020
State / ROC
Telangana / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2022
Paid Up Capital
3,052,000
Authorised Capital
5,000,000

Directors

Abhinav Rao Thangeda
Abhinav Rao Thangeda
Director/Designated Partner
about 2 years ago
Surya Prakash Madiraju
Surya Prakash Madiraju
Director/Designated Partner
over 2 years ago
Goutam Bhattacharyya
Goutam Bhattacharyya
Director/Designated Partner
about 3 years ago
Amitava Ray
Amitava Ray
Director/Designated Partner
over 3 years ago

Patents

“Cells And Methods For Obtaining Them”

Reprogrammed somatic cells  methods for reprogramming  reprogramming factors for somatic cells and uses of such factors and cells are described. Nuclear reprogramming factors [NRF] described comprise one or more of a gene product or a polynucleic acid encoding a gene product from a retinoic acid receptor (RAR/RXR) f...

Diagnostic Methods Based On Somatically Acquired Rearrangement

A monitoring method comprising identifying a somatically acquired genomic rearrangement associated with a disease state in a patient by genome wide analysis of the nucleic acid of that patient and monitoring the changes in levels of nucleic acid containing the genomic rearrangement and/or quantifying the levels of n...

Registered Trademarks

Exsegen Exsegen Genomics Research

[Class : 42] Research Services; Clinical Research Services, Conducting Clinical Trials For Others [Scientific Research], Biological Research, Clinical Research And Medical Research, Providing Medical And Scientific Research Information In The Field Of Liquid Biopsy Diagnostic Solutions, Brain Tumor Research; Structural And Functional Analysis Of Genomes.